Non-alcoholic fatty liver disease (NAFLD)
Conditions
Interventions
Intervention group:Implement a remote health management program for patients with non-alcoholic fatty liver disease based on the knowledge-belief-intention model.
control group:Conventional intervention: Issuing health education manuals for non-alcoholic fatty liver disease currently used in hospitals, and implementing regular telephone follow-up to urge timely
Sponsors
Shenzhen People's Hospital
Eligibility
Sex/Gender
All
Age
18 Years to 70 Years
Inclusion criteria
Inclusion criteria: 1. According to the diagnostic criteria for non-alcoholic fatty liver disease (NAFLD) revised in 2018, patients diagnosed with NAFLD; 2. Aged 18 years or older; 3. Assessed by the Health Behavior Capacity Scale and scored below 80% for moderate-low level of health behavior capacity; 4. No history of long-term alcohol consumption or alcohol consumption equivalent to l?ess than 140g/week for men and 70g/week for women; 5. Not receiving any medication for fatty liver disease; 6. The patient is informed and agrees to participate in this study.
Exclusion criteria
Exclusion criteria: 1. Those with a history of liver diseases (acute and chronic hepatitis, viral hepatitis, cirrhosis, autoimmune hepatitis, drug-induced hepatitis, hemochromatosis), cardiovascular diseases (coronary heart disease, myocardial infarction, angina, rheumatic heart disease, cerebrovascular accidents), kidney diseases, and malignancies; 2. Those with accompanying mental illnesses; 3. Those who have undergone regular physical exams to exclude physical diseases; 4. Those with cognitive impairment.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Liver fat content;Non-alcoholic fatty liver disease knowledge score;Score of healthy lifestyle promotion;Health Behavior Capacity Score; | — |
Secondary
| Measure | Time frame |
|---|---|
| Body Mass Index(BMI);Waist Circumference(WC);Triglyceride(TG);Total Cholesterol(TC);High-density lipoprotein cholesterol(HDL-C);Low-density lipoprotein cholesterol(LDL-C); | — |
Countries
China
Contacts
Public ContactWu Yanxia
Shenzhen People's Hospital (The Second Clinical Medical College, Jinan University; The First AffiliatedHospital, Southern University of Science and Technology)
Outcome results
None listed